The emerging field of senotherapeutic drugs

Vassilios Myrianthopoulos

doi:10.4155/fmc-2018-0234

The emerging field of senotherapeutic drugs

Future Med Chem. 2018 Oct;10(20):2369-2372. doi: 10.4155/fmc-2018-0234. Epub 2018 Oct 16.

Author

Vassilios Myrianthopoulos^{1

2

3}

Affiliations

¹ Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Panepistimiopolis Zografou, Greece.
² Department of Histology & Embryology, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
³ PharmaInformatics Unit, 'Athena' Research & Innovation Center, 15125 Athens, Greece.

PMID: 30325213
DOI: 10.4155/fmc-2018-0234

No abstract available

Keywords: BCL-2; NF-κB; PI3K/Akt; cellular senescence; dasatinib; drug repurposing; metformin; natural products; quercetin; senescence-associated secretory phenotype; senolytics; senomorphics; target-based drug discovery.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cellular Senescence / drug effects*
Drug Discovery
Humans
Nervous System Diseases / drug therapy*
Nervous System Diseases / pathology*
Small Molecule Libraries / chemistry
Small Molecule Libraries / pharmacology*

Substances

Small Molecule Libraries